Outlook Therapeutics OTLK
NASDAQ OTLK
$0.57 0.00 (-0.56%)
As of: Oct 1, 2026 · 2:48 PM EDT

Outlook Therapeutics (OTLK) Other financing activities (2015 - 2023)

Updated

Outlook Therapeutics (OTLK) reported Other financing activities of $823,894 for FY2023 (year ended Sep 30, 2023), up 37.3% from $600,000 in FY2022.

Analysis

Outlook Therapeutics (OTLK) Other financing activities (2015 - 2023) Analysis & Trends

Dating back to FY2016, Outlook Therapeutics' Other financing activities record includes 6 fiscal years.

  • Other financing activities has a five-year compound annual growth rate of -5.4% (FY2018 to FY2023).
  • The FY2023 figure ranks as the highest annual Other financing activities since FY2018.
  • According to Business Quant data, Other financing activities came in at $600,000 in FY2022 and $8,032 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Outlook Therapeutics 77.94 Mn 42.19 Mn -8,265.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 254,964.00
Dec 31, 2022 568,930.00
Dec 31, 2021 600,000.00
Dec 31, 2020 8,032.00
Sep 30, 2017 176,086.00
Dec 31, 2016 40,000.00
Dec 31, 2015 71,760.00
API Access

Outlook Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=OTLK&period=max&api_key=YOUR_API_KEY